Patients | Age (year) | Selection date | Clinical stage | NACT efficacy |
---|---|---|---|---|
1 | 45 | 2012.1.27 | Stage Ib2 | Effective |
2 | 34 | 2012.2.4 | Stage IIa | Effective |
3 | 36 | 2012.3.12 | Stage IIb | Effective |
4 | 47 | 2012.4.15 | Stage Ib2 | Not effective |
5 | 57 | 2012.4.17 | Stage Ib2 | Effective |
6 | 39 | 2012.5.15 | Stage IIa | Effective |
7 | 45 | 2012.5.18 | Stage IIa | Effective |
8 | 42 | 2012.6.3 | Stage IIb | Not effective |
9 | 32 | 2012.6.17 | Stage Ib2 | Effective |
10 | 66 | 2012.6.26 | Stage IIa | Not effective |
11 | 59 | 2012.7.14 | Stage IIb | Not effective |
12 | 46 | 2012.8.4 | Stage Ib2 | Effective |
13 | 49 | 2012.8.15 | Stage IIa | Not effective |
14 | 51 | 2012.8.24 | Stage Ib2 | Effective |
15 | 35 | 2012.8.29 | Stage Ib2 | Effective |
16 | 38 | 2012.9.16 | Stage IIa | Not effective |
17 | 40 | 2012.9.19 | Stage Ib2 | Effective |
18 | 43 | 2012.10.7 | Stage IIa | Effective |
19 | 58 | 2012.10.11 | Stage IIb | Effective |
20 | 63 | 2012.10.17 | Stage IIa | Not effective |
21 | 53 | 2012.10.19 | Stage Ib2 | Effective |
22 | 48 | 2012.10.25 | Stage Ib2 | Effective |
23 | 43 | 2012.10.28 | Stage IIa | Effective |
24 | 45 | 2012.11.1 | Stage IIb | Not effective |
25 | 44 | 2012.11.5 | Stage IIa | Effective |
26 | 61 | 2012.11.16 | Stage Ib2 | Not effective |
27 | 39 | 2012.11.23 | Stage IIa | Effective |
28 | 67 | 2012.11.25 | Stage IIa | Effective |
29 | 56 | 2012.11.30 | Stage Ib2 | Effective |
30 | 44 | 2012.12.2 | Stage Ib2 | Effective |
31 | 33 | 2012.12.10 | Stage IIa | Not effective |
32 | 54 | 2012.12.15 | Stage Ib2 | Effective |
33 | 57 | 2012.12.19 | Stage IIa | Effective |
34 | 49 | 2012.12.22 | Stage Ib2 | Effective |